AVITA Medical, Inc. (RCEL)
NASDAQ: RCEL · Real-Time Price · USD
3.910
-0.060 (-1.51%)
At close: Jun 12, 2026, 4:00 PM EDT
3.980
+0.070 (1.79%)
After-hours: Jun 12, 2026, 6:51 PM EDT

AVITA Medical Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
12051718815
Market Cap Growth
-21.09%-68.63%-5.02%111.78%-44.28%-41.55%
Enterprise Value
154.230.0523.34-30.93-70.4714.93
Last Close Price
3.913.4512.8013.726.6011.98
PS Ratio
1.660.070.260.350.24-
PB Ratio
-0.010.050.050.02-
EV/Sales Ratio
2.130.420.36-0.62-2.05-
EV/EBITDA Ratio
---0.732.56-
EV/EBIT Ratio
---0.732.56-
EV/FCF Ratio
---0.872.64-
Debt / Equity Ratio
-2.080.110.120.110-
Net Debt / Equity Ratio
-1.460.060.02-0.14-0.23-
Net Debt / EBITDA Ratio
-0.86-0.58-0.111.152.89-
Net Debt / FCF Ratio
-0.75-0.51-0.101.392.98-
Asset Turnover
1.341.050.670.480.700
Inventory Turnover
2.071.801.412.025.690
Quick Ratio
0.360.432.337.147.35-
Current Ratio
0.470.562.787.677.68-
Return on Equity (ROE)
-18.84%-12.85%-17.37%-10.17%-15.33%0.00%
Return on Assets (ROA)
-73.17%-62.52%-59.20%-40.72%-56.06%0.00%
Return on Invested Capital (ROIC)
-57.00%-90.35%-298.91%-365.41%-438.15%0.00%
Return on Capital Employed (ROCE)
364.13%-161.56%-71.95%-46.12%-63.32%0.00%
Buyback Yield / Dilution
-11.12%-7.64%-2.18%-1.32%-0.30%-9.93%
Total Shareholder Return
-11.12%-7.64%-2.18%-1.32%-0.30%-9.93%
SEC Filings: 10-K · 10-Q